Beuschlein et al. recently reported on a large multi-centre cohort of patients with ACC where Ki-67 was the best prognostic maker for overall survival when dividing the cohort into <10, 10–19 and ≥20 % [17]. This evidence concerns the gene MKI67 and adrenal cortex carcinoma.